Literature DB >> 35199749

Persistent Positivity of Reverse Transcriptase-Polymerase Chain Reaction Test among Patients with COVID-19 in Rural Teaching Hospital: A Descriptive Cross-sectional Study.

Narayani Maharjan1, Niresh Thapa2, Bibek Pun Magar3, Muna Maharjan4, Jiancheng Tu5.   

Abstract

INTRODUCTION: The persistence positivity detected for severe acute respiratory syndrome coronavirus 2 ribonucleic acid by real-time reverse transcriptase-polymerase chain reaction test in asymptomatic coronavirus disease 2019 positive patients has attracted a lot of attention. There is limited data on the duration of viral shedding. We aimed to determine the proportion of coronavirus disease patients with persistent positivity of real-time reverse transcriptase-polymerase chain reaction test in a teaching hospital of Nepal.
METHODS: A descriptive cross-sectional study was conducted using medical records from May to September 2020 in a teaching hospital of Nepal. The study was approved by the Institutional Review Committee of Karnali Academy of Health Sciences (Reference no 077/078/03). Convenient sampling method was used. Data was analysed by Statistical Package for the Social Sciences. Point estimate at 90% Confidence Interval was calculated along with frequency and proportion for binary data.
RESULTS: Of the total 95 cases, 9 (9.5%) cases (4.6-14.4 at 90% Confidence Interval), were repeat positive after achieving the first negative. The mean day required of achieving the last negative for the repeat positive group was 62.11±3.95, range (60-70 days). The mean time duration for the virus shedding was found to be 20.43±12.19 days (range 7-60 days) after the first positive test result.
CONCLUSIONS: This study concludes that there might be a persistent positivity of the polymerase chain reaction test among patients with COVID-19. The majority of the patients were test positive for 8-14 days, and some were positive till 60-70 days.

Entities:  

Keywords:  COVID-19; recurrence; reverse transcriptase-polymerase chain reaction; SARS-CoV-2; viral shedding.

Mesh:

Substances:

Year:  2021        PMID: 35199749      PMCID: PMC9124342          DOI: 10.31729/jnma.7077

Source DB:  PubMed          Journal:  JNMA J Nepal Med Assoc        ISSN: 0028-2715            Impact factor:   0.556


INTRODUCTION

The outbreak of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global public health emergency, including Nepal.[1] With the rise in cases, there are several reports on persistent or recurrent positivity of reverse transcription-polymerase chain reaction (RT-PCR) test among patients with COVID-19.[2-9] This persistence of SARS-CoV-2 RNA virus in body fluids of patients with COVID-19 may increase the potential risk of viral transmission.[10] The duration of persistence of SARS-CoV-2 virus has significant clinical and epidemiological implications.[3] However, the viral detection period in mild or asymptomatic patients with COVID-19 is still unclear. Hence, to reduce the risk of viral transmission, it is essential to know the duration of viral shedding to determine a re-testing and de-isolation plan of COVID-19 patients.[11] Thus, we aimed to determine the proportion of COVID-19 patients with persistent positivity of the RT-PCR test in a rural teaching hospital, Nepal.

METHODS

A descriptive cross-sectional study was conducted in Karnali Academy of Health Sciences (KAHS)-Teaching Hospital, Jumla, Nepal from May to September 2020. Total of 95 participants were enrolled in the study using convenience sampling. Patients with COVID-19 who were in isolation for more than 7 days in the hospital were recruited for this study. This study was approved by the Institutional Review Committee (IRC) of KAHS (IRC approval reference number: 077/078/03) Jumla, Nepal. Patients who were in an isolation ward and positive for RT-PCR test for more than one time were included in the study. The participants who refused to stay in isolation for more than 7 days or incomplete data were excluded. Convenience sampling was done and the sample size was calculated as, n = Z2 × p × q / e2 = (1.645)2 × 0.5 × (1-0.5) / 0.092 = 84 where, n= required sample size, Z= 1.645 at 90% Confidence Interval (CI), p= 50%, taken for maximum sample size q= 1-p e= margin of error, 9% Therefore, the minimum sample size calculated was 84. Non-response rate was adjusted at 10% of the sample size, the calculated sample size was 93. However, a total of 95 samples were enrolled in this study. The data was collected from the medical record book and the RT-PCR report was collected from the PCR laboratory of KAHS-Teaching Hospital. A standard format was prepared to collect the information such as date of hospital admission, hospital number, address, age, gender, ethnicity, RT-PCR test report, and duration of isolation. The nasopharyngeal and oropharyngeal specimens had been collected from the participants for detection of SARS-CoV-2 virus. The RT-PCR test was performed as per interim guidance and protocol of WHO and National Public Health Laboratories (NPHL), Nepal for SARS-CoV-2 detection in the hospital PCR laboratory.[12,13] The data were collected and sorted using Microsoft Excel (Microsoft Corporation, New York, USA) software; Statistical Package for the Social Sciences (SPSS version 16.0; IBM Analytics, New York, USA) software was used for the statistical analysis. Descriptive statistics were reported as frequency, mean, and percentage.

RESULTS

Total of 95 patients with a positive SARS-CoV-2 admitted to the isolation ward of KAHS-Teaching Hospital were recruited in this study. In this study, 9 out of 95 (9.5%) 4.6-14.4 at 90% CI) cases were repeat positive for the RT-PCR test after achieving the first negative. All of them were male. In this group, 7 out of 9 (78%) were again positive after 47th/48th day from the first positive. Similarly, 2 out of 9 (11% each) in 49th and 60th day respectively. The mean day of repeat positive for this group was 49.33±4.03, range (47-60 days). In this group of repeat positive cases, 6 out of 9 (67%) of patients achieved the last negative result on the 60th day from the first positive and the remaining 3 cases achieved the last negative result on 61st, 68th, and 70th day. The mean day required of achieving the last negative for the group was 62.11±3.95, range (6070 days) (Table 1).
Table 1

Duration of recurrent RT-PCR positive cases (n= 9).

Repeat Positive Daysn (%)Last Negative Dayn (%)
472 (22)606 (67)
485 (56)611 (11)
491 (11)681 (11)
601 (11)701 (11)
Among 95 positive cases, 37 (38.9%) and 33 (34.7%) patients were within the age group of 30-40 and 21-30 respectively. Under the age of 10, there were only 3 (3.2%) patients and over the age of 60, only 2 (2.1%). The mean age of patients was found to be 31.85±11.3, and 77 (81.1%) were male. Most of them 41 (43.2%) belonged to the Chhetri ethnic group (Table 2).
Table 2

Characteristics of patients (n=95).

Characteristicsn (%)
Age (Years)
<103 (3.2)
11-207 (7.4)
21-3033 (34.7)
30-4037 (38.9)
41-507 (7.4)
51-606 (6.3)
>602 (2.1)
Mean age±SD31.85±11.3
Gender
Male77 (81.1)
Female18 (18.9)
Ethnicity
Brahmin15 (15.8)
Chhetri41 (43.2)
Janajati12 (12.6)
Thakuri10 (10.5)
Dalit12 (12.6)
Others5 (5.3)
The mean time duration for SARS-CoV-2 RNA shedding was found to be 20.43±12.19 days (range 7-60 days) after the first positive test result. Only 34 (35.8%) of the patients achieved a negative test within 8-14 days after the first positive test and about 19 (20%) of patients required 29 and above days to achieve a negative test after the first positive test result (Table 3).
Table 3

Duration of RT-PCR positivity of patients (n=95).

Duration (Days)n (%)
≤73 (3.2)
8-1434 (35.8)
15-2129 (30.5)
22-2810 (10.5)
29 and above19 (20.0)
Mean Duration20.43±12.19
Range7-60 days
About 26 (27%) and 24 (25%) of the patients within the age group of 20-45 achieved negative results in 8-14 days and 15-21 days respectively. Only 18 (18.9%) of patients required a longer duration of 29 days and above to achieve a negative test result. In male, the highest of 24 (25.3%) patients required 15-21 days to achieve a negative test result. In female, 12 (12.6%) of patients achieved negative result within 8-14 days (Table 4).
Table 4

Characteristics of patients in relation with positivity duration of SARS-CoV-2.

Characteristics< 7 days8-14 days15-21 days22-28 days> 29 days
Age
< 191 (1.1)5 (5.3)000
20-452 (2.1)26 (27.4)24 (25.3)10 (10.5)18 (18.9)
46-6002 (2.1)4 (4.2)01 (1.1)
> 6101 (1.1)1 (1.1)00
Gender
Male3 (3.2)22 (23.2)24 (25.3)10 (10.5)18 (18.9)
Female012 (12.6)5 (5.3)01 (1.1)
Ethnicity
Brahmin06 (6.3)6 (6.3)03 (3.2)
Chhetri3 (3.2)15 (15.8)13 (13.7)3 (3.2)7 (7.4)
Janajati05 (5.3)1 (1.1)2 (2.1)4 (4.2)
Thakuri03 (3.2)6 (6.3)01 (1.1)
Dalit04 (4.2)3 (3.2)2 (2.1)3 (3.2)
Others01 (1.1)03 (3.2)1 (1.1)

DISCUSSION

Patients with COVID-19 who showed persistently positive RT-PCR test for SARS-CoV-2 have attracted a lot of attention. Some previous studies have evaluated follow-up RT-PCR results for SARS-CoV-2 among the patients who were recovered from COVID-19.[9,14,15] We determined the proportion of COVID-19 patients with persistent positivity of the RT-PCR test in our study. In this study, we estimated the time duration for positive patients with COVID-19 to clear SARS-CoV-2 RNA virus shedding. In the group of repeat positive cases, our study has shown that 9.5% (n=9) had repeat positive RT-PCR results for SARS-CoV-2 after the first negative result with a mean duration of repeat positive was 49 days (range 47-60 days). Several studies reported re-detectable positive cases after discharge.[9,14] One retrospective study in Wuhan, China also reported 7.4% (8/108) were repeat positive.[5] Further, a repeat positive case was reported in a 62 years old Japanese man. He had twice positive and negative test results over 48 days of hospitalization.[16] These findings confirmed that a certain proportion of patients may still experience conversion and prolonged RT-PCR positivity regardless of any symptoms. The reason for the recurrence of SARS-CoV-2 RNA positivity remains controversial. RT-PCR has been widely employed in diagnosing viral infections and has yielded few false-positive results.[17] We hypothesized that the reason for repeat RT-PCR positive cases might be due to the detection of viral gene fragments without active viral replication or residual "dead" viruses. Also, based on previous studies, positivity may be associated with underlying diseases, clinical status, host immune function, sampling, processing and detection.[5,9,18,19] Furthermore, the observed false-negative results have been associated with the quality of the kit as the lower limit of detection (LOD) of commercial RT-PCR kits is relatively high.[14] In the study, we found a mean duration of 20 days with a range of 7-60 days to achieve a negative RT-PCR result. Hence, the results evidenced that most patients tested positive for more than 2 weeks to achieve the first negative results in an agreement with Carmo A. et al.[11] About 35% of patients achieved negative results in 8-14 days and about 30% required 15-21 days. These results may suggest that in a situation of lack of testing resources, the patient might be re-tested only after the 20th day from the first positive test. As many other investigations also suggest for this.[6,11,20-23] In the present study, the majority of enrolled cases were asymptomatic except 7 cases who had mild symptoms. There was not any mortality case found during this study period. Only 2 cases required oxygen, one pregnant lady with heart disease and another with age over 60 years. And also, there was no requirement of using a ventilator in this group of the study population. Our findings suggest that asymptomatic COVID-19 positive individuals can remain SARS-CoV-2 RT-PCR positive for a prolonged period of time. As the COVID-19 positive cases were asymptomatic, further laboratory tests or radiological investigation was not done. Male patients were positive for a longer duration. It is difficult to compare and explain. Nevertheless, this could be due to the larger number of male patients and possibly other characteristics such as smoking, comorbid conditions which was out of the scope of this study. The study had some limitations. This is a singlecentered study with a small size of positive COVID-19 patients. We were unable to find out the risk factors associated with positive patients as most of the cases were asymptomatic. Also, we were not able to perform viral culture which is the gold standard for viral detection with infectivity.

CONCLUSIONS

This study concludes that there might be a prolonged period of persistence of SARS-CoV-2 RNA among patients with COVID-19. The majority of the patients were RT-PCR test positive for 8-14 days, and some were positive till 60-70 days among repeat positive cases.
  19 in total

1.  Prolonged SARS-CoV-2 detection and reversed RT-PCR results in mild or asymptomatic patients.

Authors:  Sung-Min Kim; Yoon Jin Hwang; Youngseok Kwak
Journal:  Infect Dis (Lond)       Date:  2020-09-16

2.  Persistence of positive severe acute respiratory syndrome coronavirus-2 reverse transcription-polymerase chain reaction test result for 24 days in a hospitalized asymptomatic carrier.

Authors:  Takahiro Uechi; Shunsuke Nakamura; Ryo Takeshita; Kyoko Morino; Ren Mizuno; Yuki Nakagawa; Yuna Irifukuhama; Shiho Takada; Hideki Teruya; Naoto Mita; Tomoki Nakamori; Hirohisa Kinoshita
Journal:  Acute Med Surg       Date:  2020-06-10

3.  Prolonged persistence of SARS-CoV-2 in the upper respiratory tract of asymptomatic infected individuals.

Authors:  S Saurabh; R Kumar; M K Gupta; P Bhardwaj; V L Nag; M K Garg; S Misra
Journal:  QJM       Date:  2020-08-01

4.  SARS-CoV-2 RNA Persistence in Naso-Pharyngeal Swabs.

Authors:  Maria Luisa Danzetta; Laura Amato; Francesca Cito; Alessandra Di Giuseppe; Daniela Morelli; Giovanni Savini; Maria Teresa Mercante; Alessio Lorusso; Ottavio Portanti; Ilaria Puglia; Federica Monaco; Claudia Casaccia; Annapia Di Gennaro; Lilia Testa; Giacomo Migliorati; Nicola D'Alterio; Paolo Calistri
Journal:  Microorganisms       Date:  2020-07-26

5.  Persistent positivity of SARS-CoV-2 nucleic acid in asymptomatic healthcare worker: infective virion or inactive nucleic acid?

Authors:  Lokesh Tiwari; Prakriti Gupta; Chandra Mani Singh; Prabhat Kumar Singh
Journal:  BMJ Case Rep       Date:  2021-03-03

6.  False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence.

Authors:  Ai Tang Xiao; Yi Xin Tong; Sheng Zhang
Journal:  J Med Virol       Date:  2020-07-11       Impact factor: 20.693

7.  Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation.

Authors:  Guangming Ye; Zhenyu Pan; Yunbao Pan; Qiaoling Deng; Liangjun Chen; Jin Li; Yirong Li; Xinghuan Wang
Journal:  J Infect       Date:  2020-03-20       Impact factor: 6.072

8.  Duration for carrying SARS-CoV-2 in COVID-19 patients.

Authors:  Xinwei Du; Xue Yu; Qingqing Li; Xianyang Li; Tao Qin; Qiankun Luo; Miaomiao Wang; Minlin Jiang; Li Bai; Xiaoping Wang; Yanfeng Pan
Journal:  J Infect       Date:  2020-04-10       Impact factor: 6.072

9.  COVID-19 with repeated positive test results for SARS-CoV-2 by PCR and then negative test results twice during intensive care: a case report.

Authors:  Masafumi Kanamoto; Masaru Tobe; Tomonori Takazawa; Shigeru Saito
Journal:  J Med Case Rep       Date:  2020-10-07

10.  Clearance and persistence of SARS-CoV-2 RNA in patients with COVID-19.

Authors:  Anália Carmo; João Pereira-Vaz; Vanda Mota; Alexandra Mendes; Célia Morais; Andreia Coelho da Silva; Elisabete Camilo; Catarina Silva Pinto; Elizabete Cunha; Janet Pereira; Margarida Coucelo; Patrícia Martinho; Lurdes Correia; Gilberto Marques; Lucília Araújo; Fernando Rodrigues
Journal:  J Med Virol       Date:  2020-06-19       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.